Clobazam
- Product NDC
- 0832-0585
- 11-digit product format
- 008320585
- Labeler code
- 0832
- Product ID
- 0832-0585_15f958c4-652f-4637-895b-4beb86a433db
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clobazam
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Upsher-Smith Laboratories, LLC
- Application
- ANDA210569
- Marketing category
- ANDA
- Marketing start
- 2018-10-22
- Marketing end
- 0000-00-00
- Substance
- CLOBAZAM
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0832-0585-25 | 00832058525 | 1 BOTTLE in 1 CARTON (0832-0585-25) > 120 mL in 1 BOTTLE | 1 bottle | 2018-10-22 | 0000-00-00 | No | No | Current |